Vanguard Asset Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.6M Buy
160,110
+3,768
+2% +$271K 0.01% 656
2026
Q2
$11M Buy
156,342
+7,787
+5% +$420K 0.01% 688
2026
Q1
$7.76M Buy
+148,555
New +$8.92M 0.01% 734

Other funds holding TECH

Vanguard Asset Management's TECH Position: Q3 2026 in Review

Vanguard Asset Management increased its Bio-Techne (TECH) stake by 2.4% in Q3 2026, buying an estimated $271K and bringing the position to 160,110 shares worth $11.6M. The position accounts for 0.01% of the portfolio, ranked #656.

Vanguard Asset Management first reported a position in TECH in Q1 2026 and has held it in 3 quarters since. 583 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • Vanguard Asset Management held 160,110 shares of Bio-Techne worth $11.6M as of Q3 2026.
  • Vanguard Asset Management bought 3,768 Bio-Techne shares in Q3 2026, an estimated $271K.
  • Bio-Techne made up 0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #656 holding.
  • Vanguard Asset Management first reported a position in Bio-Techne in Q1 2026 and has held it in 3 quarters since.
  • 583 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.